Orchestra BioMed Holdings, Inc. (OBIO)

NASDAQ: OBIO · Real-Time Price · USD

4.130

+0.190 (4.82%)

Nov 17, 2025, 4:00 PM EST - Market closed

Orchestra BioMed Holdings Employees

Orchestra BioMed Holdings had 70 employees as of December 31, 2024. The number of employees increased by 14 or 25.00% compared to the previous year.

Employees

70

Change (1Y)

14

Growth (1Y)

25.00%

Revenue / Employee

$40,257

Profits / Employee

-$1,072,871

Market Cap

233.20M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	70	14	25.00%
Dec 31, 2023	56	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

OBIO News

6 days ago - Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences - GlobeNewsWire
7 days ago - Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates - GlobeNewsWire
14 days ago - Orchestra BioMed to Host Business Update Call on November 12, 2025 - GlobeNewsWire
20 days ago - Orchestra BioMed and Terumo Enter into New $30 Million Virtue SAB Strategic Agreements - GlobeNewsWire
21 days ago - Orchestra BioMed Announces First Patients Enrolled in Virtue® SAB US Pivotal IDE Coronary Trial - GlobeNewsWire
5 weeks ago - Orchestra BioMed to Showcase Transformative Potential of AVIM Therapy in Keynote Presentation on Hypertensive Heart Disease at Georgia Innovation Summit - GlobeNewsWire
2 months ago - Orchestra BioMed Presents New AVIM Therapy Clinical Data at HRX Demonstrating Substantial and Sustained Blood Pressure Reductions that are Reproducible Upon Reactivation Following Washout - GlobeNewsWire
2 months ago - Orchestra BioMed Announces Publication of Clinical Data Demonstrating Favorable Blood Pressure and Hemodynamic Effects of AVIM Therapy in JACC: Clinical Electrophysiology - GlobeNewsWire